October 23, 2013- Interviewed by Steven E. Greer, MD
The Healthcare Channel interviewed the CEO of MannKind, Al Mann, and the CFO, Matt Pfeffer. Topics discussed include the latest clinical trial data on inhaled insulin Afrezza and the cash situation. We also discuss Mr. Mann’s other company, Second Sight, which has a Medicare and FDA-approved bionic eye to treat diseases that damage the nerves in the retina.
February 9, 2013 (20,000 people have read this article as of July 24, 2015)
Book Review by Steven E. Greer, MD
How did our ancient ancestors evolve from being pure meat eating carnivore hunters into grain fed farmers, and which diet is healthier? With nearly 7 Billion people on Read more »
Interviewed by Steven E. Greer, MD
In 1080iHD full screen for better viewing of data graphs
Manal F. Abdelmalek, MD, MPH, of the Duke Medical Center’s Division of Gastroenterology/Hepatology discusses a paper she co-authored investigating the effects on the liver of high levels of fructose typical of the American diet. The study compared the effects to glucose. The study suggests that fructose causes more fatty liver disease than other sugars.
This is a timely publication given the recent New York City ban on single serving sizes of sugary drinks that exceed 16-ounces, and builds on the body of literature supporting that regulation.
Many years ago, when I was a second-year surgery resident at NYU, I took time off to conduct research. I design some clinical studies on wounds and was awarded more Read more »